MEDRAD Multi Vendor Service Forms Alliance with Wetsco

Multi-Parametric 3.0T MRI Provides Excellent Prostate Imaging

Three different centers show that advances in imaging using MEDRAD's 3.0T eCoil™ Endorectal Coil facilitate diagnosis, localization, staging, and treatment of prostate lesions. Read Multi-parametric 3.0T MRI provides excellent prostate imaging >>

MEDRAD Heilman Center Wins National Manufacturing Excellence Award

The Association for Manufacturing Excellence (AME) presented the MEDRAD Heilman Center Electro-Mechanical Manufacturing Plant with the national Manufacturing Excellence Award. Find out more >>

MEDRAD Interventional™/Possis® Co-Sponsor ATTRACT Trial

MEDRAD Interventional/Possis, the new endovascular-focused division of MEDRAD, announced that it is a sponsor of the ATTRACT trial which will evaluate the long-term benefits of using the company’s AngioJet® Rheolytic™ Thrombectomy System in combination with clot-softening drugs to provide more rapid endovascular treatment of Deep Vein Thrombosis (DVT).

More details >>

Wireless MR Infusion System Receives FDA 510(k) Clearance

MEDRAD announced that the Continuum Wireless version of its Continuum MR Infusion System has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The new wireless option for control of medication infusion inside or outside the MR scan room will increase workflow efficiencies and throughput while enhancing clinician confidence.
Read >>